week in review

Pharma & Biotech Global Week in Review 21 March 2012 from IP Think Tank

March 21, 2012 05:32

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: Nexavar (Sorafenib) – India: Controversial licence granted over patented cancer drug (IP Whiteboard) (IPKat) (Patent...

Online Global Week in Review 16 March 2012 from IP Think Tank

March 16, 2012 00:40

Here is Think IP Strategy’s weekly selection of top Online intellectual property news breaking in the blogosphere and internet.   Highlights this week included: Samsung suffers second and even more important FRAND defeat to Apple in the Netherlands (FOSS Patents) (EPLAW) UK Home Secretary...

Pharma & Biotech Global Week in Review 14 March 2012 from IP Think Tank

March 14, 2012 06:13

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: Nexavar (Sorafenib) – India’s first compulsory license granted!: Bayer v Natco (Spicy IP) (Apothecurry) (IP...

Online Global Week in Review 9 March 2012 from IP Think Tank

March 09, 2012 05:08

Here is Think IP Strategy’s weekly selection of top Online intellectual property news breaking in the blogosphere and internet.   Highlights this week included: EWCA (Civ): Digital Economy Act is in line with EU law: British Telecommunications v BPI (The 1709 Blog) (TorrentFreak) (Out-Law)...

Pharma & Biotech Global Week in Review 7 March 2012 from IP Think Tank

March 07, 2012 10:33

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.   Highlights this week included: Co-Diovan (Valsartan, Hydrochlorothiazide) – EU: CJEU sprints to reasoned order in Case C-422/11 Novartis v...